FibroBiologics
FBLG • NASDAQ
FibroBiologics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Peter O'Heeron, with a market cap of $15.1M.
CEOPeter O'Heeron
Market Cap$15.1M
Biotechnology
Healthcare
Employees8.0
Websitefibrobiologics.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for FibroBiologics
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.10
Earnings History
Past 7 earnings reports for FibroBiologics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Oct 31, 2025 | Q3 2025 | -$0.13Est: -$0.11 | -18.2% | - | — | — |
| Jul 31, 2025 | Q2 2025 | -$0.12Est: -$0.12 | 0.0% | - | — |  10-Q |
| May 14, 2025 | Q1 2025 | -$0.14 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.09Est: -$0.07 | -28.6% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.01Est: -$0.08 | +87.5% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | $0.03Est: -$0.09 | +133.3% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.27 | — | - | — | 10-Q |